| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
61,456,000 |
| Market
Cap: |
872.06(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.9 - $16.15 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CareDx together with its subsidiaries, is a medicine company focused on the discovery, development and commercialization of diagnostic solutions for transplant patients and caregivers. Co. provides testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey, and is a provider of genomics-based information for transplant patients. Co.'s commercially available testing services consist of AlloSure® Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients, AlloMap® Heart, a solution for heart transplant patients, AlloSure® Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure® Lung.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
38,810 |
106,345 |
| Total Sell Value |
$0 |
$0 |
$359,527 |
$1,585,048 |
| Total People Sold |
0 |
0 |
2 |
3 |
| Total Sell Transactions |
0 |
0 |
9 |
21 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bell Michael Brian |
Chief Financial Officer |
• – – |
2019-02-04 |
4 |
D |
$27.17 |
$152,369 |
D/D |
(5,608) |
77,198 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2019-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
32,000 |
82,806 |
|
- |
|
| Maag Peter |
See Remarks |
• • – |
2019-01-28 |
4 |
D |
$27.46 |
$42,728 |
D/D |
(1,556) |
390,845 |
|
- |
|
| Yee James P |
Chief Medical Officer |
• – – |
2019-01-28 |
4 |
D |
$27.46 |
$23,204 |
D/D |
(845) |
56,660 |
|
- |
|
| Yee James P |
Chief Medical Officer |
• – – |
2019-01-22 |
4 |
D |
$25.05 |
$53,582 |
D/D |
(2,139) |
57,505 |
|
- |
|
| Maag Peter |
See Remarks |
• • – |
2019-01-22 |
4 |
D |
$25.05 |
$203,907 |
D/D |
(8,140) |
392,401 |
|
- |
|
| Abernethy Amy |
Director |
– • – |
2019-01-22 |
4 |
OE |
$12.88 |
$64,400 |
D/D |
5,000 |
15,837 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2019-01-22 |
4 |
D |
$25.05 |
$35,872 |
D/D |
(1,432) |
50,806 |
|
- |
|
| King Sasha |
Chief Commercial Officer |
• – – |
2019-01-02 |
4 |
OE |
$2.80 |
$12,757 |
D/D |
4,556 |
60,932 |
|
- |
|
| Goldberg Michael |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
784 |
134,740 |
|
- |
|
| Abernethy Amy |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
437 |
10,837 |
|
- |
|
| Snyderman Ralph |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
356 |
70,841 |
|
- |
|
| Bickerstaff George |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
535 |
53,473 |
|
- |
|
| King Sasha |
Chief Commercial Officer |
• – – |
2018-12-26 |
4 |
OE |
$1.00 |
$4,692 |
D/D |
2,834 |
56,376 |
|
- |
|
| Maag Peter |
See Remarks |
• • – |
2018-11-29 |
4 |
S |
$28.59 |
$223,898 |
D/D |
(7,831) |
400,541 |
|
- |
|
| Maag Peter |
See Remarks |
• • – |
2018-11-28 |
4 |
S |
$28.52 |
$2,628,614 |
D/D |
(92,169) |
408,372 |
|
- |
|
| Seeto Reginald |
SEE REMARKS |
• – – |
2018-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
| Maag Peter |
See Remarks |
• • – |
2018-11-21 |
4 |
OE |
$0.55 |
$398,795 |
D/D |
110,794 |
500,541 |
|
- |
|
| Gagnon Neil |
10% Owner |
– – • |
2018-10-31 |
4 |
S |
$27.05 |
$2,937,331 |
I/I |
(108,599) |
867,744 |
|
- |
|
| King Sasha |
Chief Commercial Officer |
• – – |
2018-10-05 |
4 |
AS |
$24.60 |
$282,900 |
D/D |
(11,500) |
53,542 |
|
- |
|
| Goldberg Michael |
Director |
– • – |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,077 |
133,956 |
|
- |
|
| Bickerstaff George |
Director |
– • – |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
734 |
52,938 |
|
- |
|
| Snyderman Ralph |
Director |
– • – |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
489 |
70,485 |
|
- |
|
| Abernethy Amy |
Director |
– • – |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
400 |
10,400 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2018-09-13 |
4 |
AS |
$25.06 |
$409,920 |
D/D |
(16,355) |
52,238 |
|
- |
|
791 Records found
|
|
Page 21 of 32 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.42 (2.87%) 
